Hikal signs long term supply pact with leading global Biopharma Company

02 Jul 2013 Evaluate

Hikal, the preferred long-term outsourcing partner for leading global life sciences companies, has signed a long term pharmaceutical supply contract with a global biopharmaceutical company. The agreement covers the production and supply from the company’s pharmaceutical division. The customer is a leading innovator company which serves markets globally for human health treatments.

Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals industries. They provide world-class Active Ingredients, Intermediates and R&D services and solutions in a safe, secure and confidential manner.

Hikal Share Price

242.40 -10.55 (-4.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×